关注
Vasily Lukyanov
Vasily Lukyanov
在 philips.com 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Cost–utility analysis of bariatric surgery
O Borisenko, V Lukyanov, AR Ahmed
Journal of British Surgery 105 (10), 1328-1337, 2018
442018
Cost-utility analysis of bariatric surgery in Italy: results of decision-analytic modelling
M Lucchese, O Borisenko, LG Mantovani, PA Cortesi, G Cesana, D Adam, ...
Obesity Facts 10 (3), 261-272, 2017
242017
Cost-effectiveness analysis of bariatric surgery for morbid obesity in Belgium
O Borisenko, V Lukyanov, I Debergh, B Dillemans
Journal of medical economics 21 (4), 365-373, 2018
212018
Cost analysis of bariatric surgery in Denmark made with a decision-analytic model
O Borisenko, V Lukyanov, SP Johnsen, P Funch-Jensen
Dan Med J 64 (8), 5401-5404, 2017
132017
Originator recombinant human follitropin alfa versus recombinant human follitropin alfa biosimilars in Spain: a cost-effectiveness analysis of assisted reproductive technology …
JE Schwarze, C Venetis, S Iniesta, E Falla, V Lukyanov, ...
Best Practice & Research Clinical Obstetrics & Gynaecology 85, 203-216, 2022
102022
Cost effectiveness of subcutaneous vedolizumab for maintenance treatment of ulcerative colitis in Canada
E Fenu, V Lukyanov, A Acs, X Radu, S Stypa, A Fischer, JK Marshall, ...
PharmacoEconomics-Open 6 (4), 519-537, 2022
72022
Cost-effectiveness analysis of recombinant human follicle-stimulating hormone alfa (r-hFSH) and urinary highly purified menopausal gonadotropin (hMG) based on data from a large …
K Bühler, C Roeder, JE Schwarze, M Lispi, A Allignol, E Falla, V Lukyanov, ...
Best Practice & Research Clinical Obstetrics & Gynaecology 85, 188-202, 2022
62022
Cost-effectiveness of single-inhaler extrafine beclometasone dipropionate/formoterol fumarate/glycopyrronium in patients with uncontrolled asthma in England
M Orlovic, T Magni, V Lukyanov, I Guerra, A Madoni
Respiratory Medicine 201, 106934, 2022
42022
POSC104 determining cost data for fertility treatment in a Spanish setting
C Roeder, V Lukyanov, E de Agustin Calvo, JE Schwarze
Value in Health 25 (1), S107, 2022
22022
Diagnostic yield of cardiac monitors in patients with suspected arrhythmias: systematic literature review and network meta-analysis
P Parikh, V Lukyanov, G Medic, M Wadhwa
Europace 26 (Supplement_1), euae102. 663, 2024
2024
EE412 Analyzing the Financial Impact of a Remote Fetal Monitoring Solution Introduction for High-Risk Pregnancies in a US Obstetrics Clinic
V Lukyanov, A Jurine-Frank, T Lashina, G Rienks, V Loewen
Value in Health 26 (6), S135, 2023
2023
Originator recombinant human follitropin alfa versus recombinant human follitropin alfa biosimilars in Spain: A cost-effectiveness analysis of assisted reproductive technology …
JE Schwarze, C Venetis, S Iniesta, E Falla, V Lukyanov, EA Calvo, ...
Best Practice & Research Clinical Obstetrics & Gynaecology 85 (Pt B), 203-216, 2022
2022
Best Practice & Research Clinical Obstetrics and Gynaecology
K Bühler, C Roeder, JE Schwarze, M Lispi, A Allignol, E Falla, V Lukyanov, ...
Best Practice & Research Clinical Obstetrics and Gynaecology 85, 188e202, 2022
2022
Outpatient cardiac telemetry monitoring for early patient discharge: continuous focused rhythm surveillance for patients recovering outside of the hospital setting
V Lukyanov, P Parikh, H Luke
J Cardiol Curr Res 15 (3), 89-92, 2022
2022
POSC152 Cost-Effectiveness Analysis of Follitropin ALFA Product (GONAL-F) Compared to Its Biosimilars Based on Meta-Analysis of Randomized Controlled Trials
V Lukyanov, E Falla, E de Agustin Calvo, JE Schwarze, T D'Hooghe, ...
Value in Health 25 (1), S116, 2022
2022
POSC109 Cost-Effectiveness Analysis of Reference Recombinant Human Follicle-Stimulating Hormone ALFA (R-HFSH-ALFA) and Urinary Highly Purified Menopausal Gonadotropin (HMG-HP …
K Bühler, C Roeder, JE Schwarze, M Lispi, A Allignol, T D'Hooghe, ...
Value in Health 25 (1), S108, 2022
2022
Economic evaluation of vedolizumab SC for the treatment of moderate-to-severe ulcerative colitis in Canada
A Fischer, M Oppe, S Stypa, V Lukyanov, I Petrakis
JOURNAL OF CROHNS & COLITIS 14, S387-S387, 2020
2020
Mast (Minimal Access Spinal Technologies) Versus Open Surgery: Cost Analysis From Hospital Perspective
V Lukyanov, D Melik-Gusseinov, B Borgman, D Demourenko, S Mlyavykh
Value in Health 17 (7), A375-A376, 2014
2014
系统目前无法执行此操作,请稍后再试。
文章 1–18